<正> Hemophilia B, affecting 1 in 30000 males, is aserious X-linked recessive bleeding disorder due to apartial or complete deficiency of human clottingfactor Ⅸ (hFⅨ) activity in the plasma. Conventionaltherapy depends on the infusion of human plasma orconcentrate. The therapeutic effect is temporary and